Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 6 hours ago
FDA halts release of new drug rejection letters while working to formalize policy
about 6 hours ago
The FDA has paused a controversial policy of releasing letters describing its...
Prime wins patent fight with Beam to continue work on AATD gene editing therapy
about 9 hours ago
Prime Medicine has come out ahead in its patent dispute with fellow...
Satellos’ ‘intriguing’ Duchenne data raise hopes ahead of key readout
about 10 hours ago
Satellos Bioscience has shared evidence that its Duchenne muscular dystrophy drug candidate...
Scipher picks up Chemomab’s rheumatoid arthritis drug, Nasdaq listing in all-stock merger
about 11 hours ago
Precision immunology company Scipher Medicine will absorb Chemomab Therapeutics after having identified...
Caidya and Simbec-Orion unite in global CRO combo
about 11 hours ago
Contract research organizations (CROs) Caidya and Simbec-Orion have united to create a...
Leo Cancer Care secures $65M series D to advance upright radiotherapy system
about 11 hours ago
Medical technology company Leo Cancer Care closed a $65 million series D...
AstraZeneca pens $2.1B Sino deal for challenger to Merck’s COPD drug Ohtuvayre
about 15 hours ago
AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to...
MeiraGTx scores $400M from Oberland Capital to help get 2 gene therapies to commercialization
1 day ago
As MeiraGTx lines up the pieces for a commercial push, the company...
Beckman Coulter grows Alzheimer’s dx portfolio with CE mark for new assay
1 day ago
Diagnostics specialist Beckman Coulter expanded its portfolio of Alzheimer’s disease diagnostics by...
Whitehawk swoops in for five ADCs via development deal with China's Biocytogen
1 day ago
Biocytogen and Whitehawk Therapeutics are joining forces to develop bispecific antibody-drug conjugates...
Endevica spinout Kalohexis submits confidential IPO filing to develop obesity challenger to GLP-1s
1 day ago
Clinical-stage Kalohexis is readying a public listing to support its obesity and...
As US lawmakers increase scrutiny of Chinese trials, industry fears ‘huge distraction and expense’
1 day ago
As U.S. lawmakers continue to scrutinize the consequences of China’s expanding role...